Department of Pancreatic Surgery, West China Hospital, Sichuan University, No. 37#, Guo Xue Xiang, Chengdu, 610041, Sichuan, China.
Department of Hepatopancreatobiliary Minimal Invasive Surgery, Chengdu ShangJin NanFu Hospital, No. 253#, ShangJin Road, High-Tech West District, Chengdu, 610063, Sichuan, China.
J Gastrointest Surg. 2021 Feb;25(2):576-577. doi: 10.1007/s11605-020-04829-7. Epub 2020 Oct 19.
Splenic littoral cell angioma (LCA) is a rare vascular tumor with malignant potential originating from the red pulp of the spleen.1,2 Although laparoscopic splenectomy is the treatment choice for LCA, patients suffer from long-term complications of sepsis, thrombosis, and tumor.4,5 Laparoscopic central splenectomy (LCS) for LCA is a technically challenging operation mainly due to the risk of intraoperative hemorrhage. However, it can be a valuable alternative particularly for adolescent patients in whom maximum preservation of splenic function outweighs the risks associated with organ preservation.
A 15-year-old young man was admitted with left upper abdominal dull pain for 1 month. Laboratory tests and enhanced abdominal CT scans were performed. Laboratory test results were all normal, as follows: complete blood count showed normal WBC: 5.74 × 10/l, platelets: 173 × 10/l, Hb: 151 g/l, tumor markers (CEA: 1.62 ng/ml, CA19-9: 10.30 U/ml, AFP: 1.13 ng/ml) which were within normal limits. CT scan showed that a 5 × 5.9-cm solid tumor was discovered in the middle part of the spleen during diagnosis, and the density of this tumor was high in the early artery phase and low in the late portal venous phase of contrast-enhanced CT. LCS was performed where the trunk of the splenic artery was intermittently occluded and several branches of the vessels were freed from the tumor which was then resected. The splenic parenchyma was dissected by following a line 0.5 cm from demarcation line. The tumor was completely removed with the activity of the splenic parenchyma being preserved to the maximum extent. Total operation time was 175 min, with an estimated blood loss of 200 ml; thus, no blood transfusion was required. Intraoperative frozen section suggested vascular tumor-like lesions, and then the tumor was completely removed with the resection margin being free of tumor involvement.
The patient was fully recovered after a 7-day hospital stay. The reason for the 7-day hospital stay is that the patient maintains normal ambulating independent assistance on POD-3 and can eat without intravenous fluids on POD-4. Meanwhile, the patient needs to remove the drainage tube after the abdominal CT scan on POD-6, rather than postoperative complications. Diagnosis of LCA was confirmed using histology, and the symptoms disappearing after the operation was done. A total of 86·laparoscopic partial splenectomy (LPS) procedures were performed at the Department of Pancreatic Surgery, West China Hospital and Department of Hepatopancreatobiliary Minimal Invasive Surgery, Chengdu ShangJin NanFu Hospital from May 2011 to May 2020. Five patients among the total number of patients were diagnosed with LCA of which LPS was performed in four patients and LCS performed for one patient. The mean duration of surgery for LPS was 100 min (range of 80-120 min) while the mean estimated blood loss was 125 ml (range of 100-200 ml). On the other hand, the mean length of hospital stay was 7.5 days (range of 5-11 days) and the mean tumor diameter was 5.1 cm (range of 3.2-7 cm). All patients recovered without complications. In addition, there were no signs of immune insufficiency, thrombosis, and tumor recurrence during the follow-up which had a mean of 31.2 months (range from 10 to 53 months).
LCS is a technically feasible technique for a select group of patients with centrally located LCA. The technique helps to maximize preservation of splenic function and maintains the advantages of minimally invasive surgery.
脾边缘区细胞血管瘤(LCA)是一种起源于脾脏红髓的潜在恶性的罕见血管肿瘤。1,2 尽管腹腔镜脾切除术是 LCA 的治疗选择,但患者会长期遭受感染、血栓和肿瘤等并发症的困扰。4,5 对于 LCA,腹腔镜中央脾切除术(LCS)是一种技术上具有挑战性的手术,主要是因为术中出血的风险。然而,对于青少年患者来说,它可能是一种有价值的替代方法,因为最大限度地保留脾脏功能比器官保存带来的风险更为重要。
一名 15 岁的年轻男性因左上腹痛 1 个月入院。进行了实验室检查和增强腹部 CT 扫描。实验室检查结果均正常,具体如下:全血细胞计数显示 WBC:5.74×10/l,血小板:173×10/l,Hb:151g/l,肿瘤标志物(CEA:1.62ng/ml,CA19-9:10.30U/ml,AFP:1.13ng/ml)均在正常范围内。CT 扫描显示在诊断过程中脾中部发现了一个 5×5.9cm 的实性肿瘤,该肿瘤在动脉早期增强 CT 扫描时密度较高,在门静脉晚期时密度较低。行 LCS,间断阻断脾动脉干,游离数支肿瘤供血血管,然后将肿瘤切除。沿 0.5cm 距离肿瘤边界进行脾实质解剖。保留最大程度的脾实质活性,完全切除肿瘤。总手术时间为 175 分钟,估计失血量为 200ml,因此无需输血。术中冷冻切片提示为血管肿瘤样病变,然后完全切除肿瘤,切除边缘无肿瘤累及。
患者在住院 7 天后完全康复。住院 7 天的原因是患者在术后第 3 天可以独立行走且不需要静脉输液,第 4 天可以正常进食。同时,患者需要在术后第 6 天进行腹部 CT 扫描后拔除引流管,而不是出现术后并发症。组织学证实为 LCA,术后症状消失。2011 年 5 月至 2020 年 5 月,华西医院胰腺外科和成都上锦南府医院肝胆微创外科共进行了 86 例腹腔镜部分脾切除术(LPS)。在总共的患者中,有 5 例被诊断为 LCA,其中 4 例行 LPS,1 例行 LCS。LPS 的平均手术时间为 100 分钟(80-120 分钟),平均估计出血量为 125ml(100-200ml)。另一方面,平均住院时间为 7.5 天(5-11 天),平均肿瘤直径为 5.1cm(3.2-7cm)。所有患者均无并发症恢复。此外,在随访期间,没有出现免疫功能不全、血栓形成和肿瘤复发的迹象,随访时间平均为 31.2 个月(10-53 个月)。
LCS 是一种技术上可行的方法,适用于中央型 LCA 的特定患者群体。该技术有助于最大限度地保留脾脏功能,并保持微创外科的优势。